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Case Reports
Severe Hypercalcemia in Tuberculosis
A. Soofi, A. Malik, J. Khan, S. Muzaffar*
Departments of Medicine and Pathology*, The Aga Khan University, Karachi.
Introduction
Hypercalcemia is known to occur in granulomatous
diseases.1 Sarcoidosis is the most common granulomatous
disease causing hypercalcemia. Tuberculosis, fungal
granulomas, berryliosis and lymphomas are other
conditions that are associated with disorders of calcium
metabolism.2 Hypercalcemia, although occurs infrequently,
is a well recognized complication of active tuberculosis.
Severe hypercalcemia has been rarely reported in literature.
The reported incidence of hypercalcemia in TB varies
widely between countries, probably because of variations in
the Vitamin D and calcium intake, the amount of sun
exposure and differences in study population.3 We describe
here a case of severe hypercalcemia in a patient with
abdominal tuberculosis.
Case Report
A 55 years old male presented with low grade fever,
generalized weakness, weight loss, abdominal distension
and constipation for 4 months and urinary frequency for 2
months. On examination, he looked cachectic with
distended abdomen. There was no peripheral
lymphadenopathy. Neurological and chest examination
were normal.
Abdominal examination revealed gross ascites.
Laboratory workup showed normocytic normochromic
anemia with a hemoglobin of 10.8 gm/dl, white blood cell
count of 9 x 109/L with normal differentials, albumin of
2.4gm/dl, corrected hypercalcemia of 15.:mg/dl, raised
alkaline phosphatase (764 I.U/L) with normal parathyroid
hormone  level (19.7 pg/ml) and progressive renal failure.
His serum creatinine rose from 0.9mg/dl two months prior
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to emergency room presentation to 4.1 mg/dl three days
post hospital admission. Ultrasound abdomen showed gross
ascites and multiple hypoechoic lesions in right lobe of
liver.
Diagnostic ascitic fluid tap revealed exudative
ascites (glucose 97 mg/dl, protein 5500mg/dl, leukocyte
count 400/mm3 with 97% lymphocytes). Ascitic fluid smear
for Acid Fast Bacilli and culture were negative. Ascitic fluid
cytology did not show any malignant cells. Computed
Tomography scan of abdomen showed diffuse peritoneal
thickening with abdominal lymphadenopathy, irregular
pleura, thickening of posterior wall of stomach, lesser
curvature, antrum and omentum. Ultrasound guided trucut
biopsy of peritoneum revealed chronic granulomatous
inflammation. Granuloma was composed of epitheloid
cells, multinucleated giant cells, plasma cells and
lymphocytes (Figure).
The patient was started on rifampicin 450mg,
isoniazid 300mg, ethambutol 1200mg and pyrazinamide
1500mg once daily for two months with aggressive
hydration. He showed marked improvement within three
weeks of therapy. His calcium and creatinine decreased to
9.1 mg/dl and 1.7mg/dl respectively. For the maintenance
phase, he was continued on isoniazid and ethambutol for six
months.
Discussion
Hypercalcemia is not an uncommon problem seen in
medical practice. More than 90% of cases are due to
primary hyperparathyroidism and malignancy. Other causes
besides granulomatous diseases include vitamin D
intoxication, hyperthyroidism, thiazide diuretics, lithium,
milk alkali syndrome and immobilization.
The diagnosis of tuberculosis in this case was made
on the presence of typical histology showing epitheloid
granuloma, symptomatic hypercalcemia and improvement
with antituberculous chemotherapy. A case of
hypercalcemic crisis as the presenting manifestation of
abdominal tuberculosis has been described by Ramanathan
et al.4 Our finding of rapid response of hypercalcemia to
anti tuberculosis treatment is consistent with the case
reported by Tan et. al. in which hypercalcemia in a patient
with abdominal tuberculosis lympadenopathy returned to
normal within one month of anti-tuberculosis treatment.5
Hypercalcemia manifests as polyuria, polydipsia,
vomiting, dehydration, constipation and mental obtundation
in absence of CNS disease. ECG finding is shortened QT
interval. In patients with tuberculosis, hypercalcemia is
usually mild and asymptomatic.6 It may occur in all forms
of tuberculosis - both pulmonary and extra pulmonary. The
difference in serum calcium levels among different forms of
tuberculosis has not been found to be statistically
significant. However very high levels have been noted in
patients with disseminated tuberculosis and pulmonary
tuberculosis with pleural effusion. Severe hypercalcemia, as
was in this case, has been infrequently reported. In a series
from Hong Kong.7 only 2 out of 318 patients with active TB
had hypercalcemia severe enough to be treated with
hydration and steroids. The causes of severe hypercalcemia
associated with TB quoted in literature are Vitamin
D/calcium supplementation and renal failure.8 Our patient
was not receiving any supplements so the probable cause of
severe hypercalcemia in our patient was impaired renal
function.
Our patient was cachectic and had
hypoalbuminemia. Both, protein caloric malnutrition and
hypoalbuminemia are common observations in patients
with active tuberculosis. In a study done by Liam et. aI.,
66% of patients with active TB had hypoalbuminemia at the
time of diagnosis.9 The reasons for this are mostly chronic
ill health as a result of TB and malnutrition related to low
socioeconomic background.
Regarding the mechanism of hypercalcemia, there is
evidence that extra renal I-alpha hydroxylation of 25
hydroxy cholcalciferol to 1,25 dihydroxycholecalciferol
brought about by macrophages plays an important role in
causing hypercalcemia in tuberculous patients.l0 This 1-
enzyme activity in macrophages is regulated by gamma
interferon or endotoxin. It is thought that 1,25
dihydroxycholecalciferol can improve the capacity of
activated macrophages to kill mycobacteria.11 This activity
usually has local effects to enhance all cell-mediated
immunity to TB. However if produced in a large quantity,
spillage may occur into circulation resulting in
hypercalcemia.
Symptomatic hypercalcemia is managed by
aggressive hydration and occasionally short courses of
systemic corticosteroid to bring down the serum calcium
level as was done in our patient.
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In conclusion, we suggest that TB should be
excluded in any febrile patient with hypercalcemia
especially in countries where tuberculosis is endemic.
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Anti-Rh17 (Anti-Hr0): a rare Diagnostic and Management Problem 
N. Salamat, F. A. Bhatti, A. Hussain, Ziaullah
Armed Forces Institute of Transfusion, Rawalpindi.
Introduction
Of all blood group systems, anti Rh antibodies are
the commonest cause of haemolytic disease of the newborn
(HDN) and its diagnosis and management plan is well
established. Also immunization with 'D' antigen can be
effectively prevented by prophylactic use of anti-D
Immunoglobulin. Therefore its prevalence has declined but
now less common alloantibodies are frequently encountered
posing different management problems. Anti Rh17 is also a
rare alloantibody1 produced after immune stimulus, by
individuals who lack C/c and E/e antigens of Rh blood
group on their red cells. This rare blood group is designated
as D- - and was first described by Race and Sanger2 in 1950.
We report diagnosis and management of a pregnant lady
with anaemia, mitral valve disease and anti Rh17
alloantibody who required blood for operation and her baby
suffered from hydrops foetalis.
Case Report
A 35 years old lady, (gravida 4, term 2, premature
0, abortion 0, live birth 1) diagnosed case of moderately
severe mitral valve stenosis was admitted in Armed Forces
Institute of Cardiology (AFIC) with amenorrhoea of 7
months duration, shortness of breath NYHA III/IV and
palpitations for 5 months. Her first pregnancy ended in
intrapartum death in 1998 at full term. Next year a full term
healthy boy was delivered by Caesarean-section and patient
was transfused one unit of whole blood in post partum
period. The child did not have a history of neonatal jaundice
or anaemia. In 2001 her next pregnancy ended with
intrauterine death at 34th week of gestation and dead
hydropic fetus was delivered by Caesarean-section. Fourth
pregnancy started in Oct 2002 and she became
progressively dyspnoeic, had palpitations and was
hospitalized. Her physical examination revealed
tachycardia with regular rhythm, BP of 110/70 mmHg,
respiratory rate 24/min and pitting edema of both feet.
Grade II diastolic murmur was audible on precordium.
Abdominal fundal height was 38 weeks while gestational
age by dates was 34 weeks. Her haemoglobin level was 4.3
g/dl, with red cells showing microcytosis and hypochromia.
Echocardiography showed moderately severe mitral
stenosis and ejection fraction of 65%. Rest all of the
investigations were within normal limits. Ultrasound of
abdomen revealed single alive foetus with ascites and
pleural effusion, suggesting hydrops foetalis, whereas
placenta was large and fundal and she had developed
polyhydramnios. She was prescribed 1/V injection of Iron
sucrose (Venofer) 20 mg/day for 6 days and also received
oral iron/folic acid 200 mg, Spironolactone 40 mg, and
Digoxin 0.25 mg every day. Clotted blood sample of the
patient was sent to our centre for grouping and cross
matching. The serological test3 and results following this
request are summarized in Table 1. Interpretation of these
results was that patient is having IgG type, alloantibody,
directed against some high frequency (public) red cell
antigen. To determine the specificity of antibody and to find
compatible blood, rare red cells panels and antisera were
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